New CEO Appointed at Carl Zeiss Meditec AG

Carl Zeiss Meditec AG has concluded its search for a new long-term Chief Executive Officer. The Supervisory Board appointed Ms. Bronwyn Brophy O’Connor, currently the CEO of Vitrolife Group in Sweden, during its meeting on May 19, 2026. Ms. Brophy O’Connor is set to replace the interim CEO, Mr. Andreas Pecher. Her extensive experience of 25 years in medical technology and Life Sciences positions her well for this leadership role.

Ms. Brophy O’Connor's start date with Carl Zeiss Meditec AG will be announced following negotiations with her current employer. Meanwhile, Mr. Pecher will continue in his interim CEO duties. Alongside her CEO role at Meditec AG, Ms. Brophy O’Connor will join the Executive Board of Carl Zeiss AG. The transition supports the strategic realignment goals of the company.